SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aesthetic Medical International Holdings Group Ltd. – ‘F-3’ on 6/17/22 – ‘EX-23.2’

On:  Friday, 6/17/22, at 8:51am ET   ·   Accession #:  1104659-22-72201   ·   File #:  333-265667

5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/17/22  Aesthetic Medical Int’l Hold… Ltd F-3                    5:591K                                   Toppan Merrill/FA

Registration Statement by a Foreign Issuer – Securities for a Transaction   —   Form F-3

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-3         Registration Statement by a Foreign Issuer -        HTML    234K 
                Securities for a Transaction                                     
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     27K 
 3: EX-23.2     Consent of Expert or Counsel                        HTML      7K 
 4: EX-23.3     Consent of Expert or Counsel                        HTML      6K 
 5: EX-FILING FEES  Filing Fees                                     HTML     11K 


‘EX-23.2’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 23.2

 

 

Date: June 17, 2022

 

Aesthetic Medical International Holdings Group Limited (the “Company”) 

1122 Nanshan Boulevard, 

Nanshan District, Shenzhen, 

Guangdong Province, China 518052

 

Dear Sirs/Madams,

 

We hereby consent to the reference to our firm in the Company’s proposed offering (the “Offering”) of a certain number of ordinary shares, including in the form of American Depositary Shares, or ADSs, warrants to purchase ordinary shares of the Company, as set forth in the Company’s registration statement on Form F-3, including a base prospectus, and the prospectus supplement, including any amendments or supplements thereto (the “Registration Statement”), filed by the Company with the Securities and Exchange Commission under the U.S. Securities Act of 1933 (as amended) in relation to the Offering.

 

In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, or under the Securities Exchange Act of 1934, in each case, as amended, or the regulations promulgated thereunder.

 

Yours Sincerely,

 

 

/s/ Han Kun Law Offices 
HAN KUN LAW OFFICES 

 

 

 

 C: 

 


Dates Referenced Herein

This ‘F-3’ Filing    Date    Other Filings
Filed on:6/17/22None on these Dates
 List all Filings 


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/31/22  Aesthetic Medical Int’l Hold… Ltd 6-K         5/31/22    3:293K                                   Toppan Merrill/FA
 5/16/22  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/21  186:28M                                    Toppan Merrill/FA
 4/30/21  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/20  206:35M                                    Toppan Merrill/FA
 4/30/20  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/19  189:30M                                    Toppan Merrill/FA
 9/30/19  Aesthetic Medical Int’l Hold… Ltd F-1                   23:9.3M                                   Toppan Merrill-FA
Top
Filing Submission 0001104659-22-072201   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 6:44:51.1am ET